Annual Net Margin
-1863.36%
-740.28%-65.92%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual net profit margin is -1863.36%, with the most recent change of -740.28% (-65.92%) on December 31, 2023.
- During the last 3 years, CYTH annual net margin has fallen by -873.56% (-88.26%).
- CYTH annual net margin is now -2241.79% below its all-time high of 87.00%, reached on December 31, 2007.
Performance
CYTH Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-3778.44%
+1080.26%+22.23%
September 30, 2024
Summary
- As of February 8, 2025, CYTH quarterly net profit margin is -3778.44%, with the most recent change of +1080.26% (+22.23%) on September 30, 2024.
- Over the past year, CYTH quarterly net margin has dropped by -1966.49% (-108.53%).
- CYTH quarterly net margin is now -5938.13% below its all-time high of 64.72%, reached on September 30, 2002.
Performance
CYTH Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
CYTH Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.9% | -108.5% |
| 3 y3 years | -88.3% | -108.5% |
| 5 y5 years | -342.9% | -108.5% |
CYTH Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -106.8% | at low | -691.7% | +22.2% |
| 5 y | 5-year | -149.2% | at low | -691.7% | +22.2% |
| alltime | all time | -2241.8% | at low | -5938.1% | +22.2% |
Cyclo Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -3778.44%(-22.2%) |
| Jun 2024 | - | -4858.70%(+126.5%) |
| Mar 2024 | - | -2145.25%(+18.4%) |
| Dec 2023 | -1863.36%(+65.9%) | -1811.95%(+88.2%) |
| Sep 2023 | - | -962.98%(-75.7%) |
| Jun 2023 | - | -3958.79%(+20.5%) |
| Mar 2023 | - | -3285.25%(+23.2%) |
| Dec 2022 | -1123.08%(+24.7%) | -2666.14%(+183.9%) |
| Sep 2022 | - | -939.23%(+47.4%) |
| Jun 2022 | - | -637.03%(-55.2%) |
| Mar 2022 | - | -1422.03%(+198.0%) |
| Dec 2021 | -900.94%(-9.0%) | -477.24%(-50.1%) |
| Sep 2021 | - | -955.70%(-36.6%) |
| Jun 2021 | - | -1507.77%(+33.8%) |
| Mar 2021 | - | -1127.13%(-38.8%) |
| Dec 2020 | -989.80%(+32.3%) | -1840.57%(+185.2%) |
| Sep 2020 | - | -645.33%(-38.3%) |
| Jun 2020 | - | -1046.02%(+29.4%) |
| Mar 2020 | - | -808.63%(-30.2%) |
| Dec 2019 | -747.87%(+77.8%) | -1158.95%(+103.9%) |
| Sep 2019 | - | -568.47%(+13.5%) |
| Jun 2019 | - | -500.93%(-41.9%) |
| Mar 2019 | - | -862.29%(+51.2%) |
| Dec 2018 | -420.68%(+35.8%) | -570.14%(+62.6%) |
| Sep 2018 | - | -350.72%(-4.9%) |
| Jun 2018 | - | -368.97%(-10.1%) |
| Mar 2018 | - | -410.43%(-50.0%) |
| Dec 2017 | -309.68%(+10.2%) | -821.57%(+212.6%) |
| Sep 2017 | - | -262.81%(+66.1%) |
| Jun 2017 | - | -158.25%(-51.1%) |
| Mar 2017 | - | -323.70%(+105.3%) |
| Dec 2016 | -281.04%(+4.7%) | -157.68%(-72.8%) |
| Sep 2016 | - | -580.50%(+108.3%) |
| Jun 2016 | - | -278.67%(+23.5%) |
| Mar 2016 | - | -225.71%(-65.3%) |
| Dec 2015 | -268.44%(+610.0%) | -650.44%(+104.2%) |
| Sep 2015 | - | -318.57%(+236.4%) |
| Jun 2015 | - | -94.70%(-57.8%) |
| Mar 2015 | - | -224.17%(+215.2%) |
| Dec 2014 | -37.81%(-412.5%) | -71.13%(+24.8%) |
| Sep 2014 | - | -57.01%(-34.7%) |
| Jun 2014 | - | -87.24%(-604.3%) |
| Mar 2014 | - | 17.30%(-148.0%) |
| Dec 2013 | 12.10%(+70.4%) | -36.02%(-36.2%) |
| Sep 2013 | - | -56.50%(-251.8%) |
| Jun 2013 | - | 37.23%(+80.9%) |
| Mar 2013 | - | 20.58%(-53.1%) |
| Dec 2012 | 7.10% | 43.90%(-251.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | -29.06%(-23.7%) |
| Jun 2012 | - | -38.08%(-467.6%) |
| Mar 2012 | - | 10.36%(-125.4%) |
| Dec 2011 | -9.47%(+102.4%) | -40.84%(+86.4%) |
| Sep 2011 | - | -21.91%(-328.7%) |
| Jun 2011 | - | 9.58%(-338.3%) |
| Mar 2011 | - | -4.02%(-116.9%) |
| Dec 2010 | -4.68%(-84.9%) | 23.80%(-226.3%) |
| Sep 2010 | - | -18.84%(-213.3%) |
| Jun 2010 | - | 16.63%(-130.8%) |
| Mar 2010 | - | -53.99%(-60.6%) |
| Dec 2009 | -30.96%(-62.9%) | -136.92%(-1000.8%) |
| Sep 2009 | - | 15.20%(-277.6%) |
| Jun 2009 | - | -8.56%(-80.5%) |
| Mar 2009 | - | -43.95%(-83.9%) |
| Dec 2008 | -83.49%(-196.0%) | -273.73%(<-9900.0%) |
| Sep 2008 | - | 1.12%(-120.2%) |
| Jun 2008 | - | -5.55%(-94.4%) |
| Mar 2008 | - | -98.27%(-418.1%) |
| Dec 2007 | 87.00%(-563.3%) | - |
| Sep 2007 | - | 30.89%(-34.8%) |
| Jun 2007 | - | 47.36%(+2062.6%) |
| Mar 2007 | - | 2.19%(-806.5%) |
| Dec 2006 | -18.78%(-50.5%) | -0.31%(-99.4%) |
| Sep 2006 | - | -55.11%(+267.4%) |
| Jun 2006 | - | -15.00%(+24.8%) |
| Mar 2006 | - | -12.02%(-96.9%) |
| Dec 2005 | -37.96%(-68.6%) | -393.62%(+526.7%) |
| Sep 2005 | - | -62.81%(-496.0%) |
| Jun 2005 | - | 15.86%(-105.0%) |
| Dec 2004 | -120.83%(-275.4%) | -318.57%(-3883.5%) |
| Sep 2004 | - | 8.42%(-103.4%) |
| Jun 2004 | - | -249.19%(+1112.6%) |
| Mar 2004 | - | -20.55%(-163.6%) |
| Dec 2003 | 68.88%(+117.3%) | - |
| Sep 2003 | - | 32.32%(+40.3%) |
| Jun 2003 | - | 23.04%(-202.0%) |
| Mar 2003 | - | -22.58%(-54.5%) |
| Dec 2002 | 31.70%(-180.6%) | -49.61%(-176.7%) |
| Sep 2002 | - | 64.72%(+61.0%) |
| Jun 2002 | - | 40.21%(+46.9%) |
| Mar 2002 | - | 27.37%(-145.4%) |
| Dec 2001 | -39.35%(-56.4%) | -60.30%(-30.2%) |
| Sep 2001 | - | -86.37%(<-9900.0%) |
| Jun 2001 | - | 0.10%(-100.3%) |
| Mar 2001 | - | -31.42%(-83.4%) |
| Dec 2000 | -90.27% | -189.04%(+88.5%) |
| Sep 2000 | - | -100.29% |
FAQ
- What is Cyclo Therapeutics annual net profit margin?
- What is the all time high annual net margin for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual net margin year-on-year change?
- What is Cyclo Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly net margin year-on-year change?
What is Cyclo Therapeutics annual net profit margin?
The current annual net margin of CYTH is -1863.36%
What is the all time high annual net margin for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual net profit margin is 87.00%
What is Cyclo Therapeutics annual net margin year-on-year change?
Over the past year, CYTH annual net profit margin has changed by -740.28% (-65.92%)
What is Cyclo Therapeutics quarterly net profit margin?
The current quarterly net margin of CYTH is -3778.44%
What is the all time high quarterly net margin for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly net profit margin is 64.72%
What is Cyclo Therapeutics quarterly net margin year-on-year change?
Over the past year, CYTH quarterly net profit margin has changed by -1966.49% (-108.53%)